ACM
Avalon Capital Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-11,463
| Closed | -$1.79M | – | 89 |
|
|
2017
Q3 | $1.79M | Sell |
11,463
-253
| -2% | -$39.6K | 1.24% | 27 |
|
|
2017
Q2 | $1.82M | Sell |
11,716
-11,044
| -49% | -$1.71M | 1.34% | 29 |
|
|
2017
Q1 | $3.44M | Buy |
+22,760
| New | +$3.44M | 2.38% | 11 |
|
|
2016
Q1 | – | Sell |
-12,493
| Closed | -$2.02M | – | 80 |
|
|
2015
Q4 | $2.02M | Hold |
12,493
| – | – | 1.82% | 20 |
|
|
2015
Q3 | $1.85M | Sell |
12,493
-247
| -2% | -$36.6K | 1.7% | 24 |
|
|
2015
Q2 | $2.23M | Sell |
12,740
-14,966
| -54% | -$2.62M | 2.03% | 19 |
|
|
2015
Q1 | $4.78M | Buy |
27,706
+10,265
| +59% | +$1.77M | 3.86% | 6 |
|
|
2014
Q4 | $2.64M | Buy |
17,441
+3,824
| +28% | +$579K | 2.03% | 21 |
|
|
2014
Q3 | $1.91M | Buy |
13,617
+9,467
| +228% | +$1.33M | 1.59% | 19 |
|
|
2014
Q2 | $561K | Hold |
4,150
| – | – | 0.47% | 72 |
|
|
2014
Q1 | $526K | Sell |
4,150
-2,250
| -35% | -$285K | 0.43% | 78 |
|
|
2013
Q4 | $756K | Hold |
6,400
| – | – | 0.64% | 50 |
|
|
2013
Q3 | $681K | Sell |
6,400
-400
| -6% | -$42.6K | 0.67% | 44 |
|
|
2013
Q2 | $678K | Buy |
+6,800
| New | +$678K | 0.67% | 48 |
|